Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 14, 2019

SELL
$14.92 - $19.94 $2.06 Million - $2.76 Million
-138,185 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$19.74 - $25.65 $5.17 Million - $6.72 Million
-261,815 Reduced 65.45%
138,185 $2.73 Million
Q1 2019

May 15, 2019

BUY
$22.17 - $24.0 $8.87 Million - $9.6 Million
400,000 New
400,000 $9.6 Million

Others Institutions Holding GNFT

About Genfit S.A.


  • Ticker GNFT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,815,500
  • Market Cap $207M
  • Description
  • Genfit S.A., a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company's products include Elafibranor, which is in Phase 3 clinical trial to treat patients with primary biliary cholangitis. It also engages in the development of NIS4 technology for the diagno...
More about GNFT
Track This Portfolio

Track Cvi Holdings, LLC Portfolio

Follow Cvi Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cvi Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cvi Holdings, LLC with notifications on news.